Treatment of Herpes Simplex Labialis

Herpes

Volumn 9, Issue 3, 2002, Pages 64-69

  Spruance, Spotswood L ^a   Kriesel, John D ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Aciclovir; Famciclovir; Herpes simplex labialis; Penciclovir; Treatment; Valaciclovir

Indexed keywords

ACICLOVIR; ANBESOL; ANTIVIRUS AGENT; BEHENYL ALCOHOL; BLISTEX; CAMPHO-PHENIQUE; CLOTRIMAZOLE; CORTICOSTEROID; DIMETHYL SULFOXIDE; FAMCICLOVIR; FLUOCINONIDE; FOSCARNET; HERPECIN L; HYDROCORTISONE; IDOXURIDINE; LIDEX GEL; NUCLEOSIDE DERIVATIVE; PENCICLOVIR; VALACICLOVIR; VIRACTIN; ANTIINFLAMMATORY AGENT; STEROID;

CLINICAL TRIAL; DRUG EFFICACY; DRUG FORMULATION; ERYTHEMA MULTIFORME; HERPES LABIALIS; HUMAN; INFECTION PREVENTION; MORBIDITY; PATIENT SELECTION; PRIORITY JOURNAL; RECURRENT INFECTION; REVIEW; STEROID THERAPY; TREATMENT INDICATION; ULTRAVIOLET RADIATION; VIRUS REACTIVATION; VIRUS TRANSMISSION; CONTROLLED CLINICAL TRIAL; DRUG ADMINISTRATION ROUTE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE;

HERPES;

ANTI-INFLAMMATORY AGENTS; ANTIVIRAL AGENTS; DRUG ADMINISTRATION ROUTES; HERPES LABIALIS; HUMANS; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; STEROIDS;

EID: 0036885002     PISSN: 09697667     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Ship II, Morris AL, Durocher RT, Burket LW. Recurrent aphthous ulcerations and recurrent herpes labialis in a professional school student population. Oral Surg Oral Med Oral Pathol 1960;13: 1191-1202.
2. Embil JA, Stephens RG, Manuel FR. Prevalence of recurrent herpes labialis and aphthous ulcers among young adults on six continents. Can Med Assoc J 1975;113:627-630.
3. Grout P, Barber VE. Cold sores - an epidemiologic survey. J Roy Coll Gen Prac 1976;26:428-434.
4. Young SK, Rowe NH, Buchanan RA. A clinical study for the control of facial mucocutaneous herpes virus infections. I. Characterization of natural history in a professional school population. Oral Surg Oral Med Oral Pathol 1976;41:498-507.
5. Huff JC. Erythema multiforme and latent herpes simplex infection. Semin Dermatol 1992;11:207-210.
6. Stanberry LR, Cunningham AL, Mindel A, Scott LL, Spruance SL, Aoki FY et al. Prospects for control of herpes simplex virus disease through immunization. Clin Infect Dis 2000;30:549-566.
7. McKeough MB, Spruance SL. Comparison of new topical treatments for herpes labialis: efficacy of penciclovir cream, acyclovir cream, and n-docosanol cream against experimental cutaneous herpes simplex virus type 1 infection. Arch Dermatol 2001;137: 1153-1158.
8. Khalil MH, Marcelletti JF, Katz LR, Katz DH, Pope LE. Topical application of docosanol- or stearic acid-containing creams reduces severity of phenol bum wounds in mice. Contact Dermatitis 2000;43:79-81.
9. Spruance SL, Wenerstrom G. Pathogenesis of herpes simplex labialis: IV. Maturation of lesions within 8 hours after onset and implications for antiviral treatment. Oral Surg Oral Med Oral Pathol 1984;58:667-671.
10. Spruance SL, McKeough MB, Sugibayashi K, Robertson F, Gaede P, Clark DS. Effect of azone and propylene glycol on penetration of trifluorothymidine through skin and the efficacy of different topical formulations against cutaneous herpes simplex virus infection in guinea pigs. Antimicrob Agents Chemother 1984;26:819-823.
11. Spruance SL, Rea TL, Thoming C, Tucker R, Saltzman R, Boon R. Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group. JAMA 1997;277: 1374-1379.
12. Spruance SL, Schnipper LE, Overall JC, Jr, Kern ER, Wester B, Modlin J et al. Treatment of herpes simplex labialis with topical acyclovir in polyethylene glycol. J Infect Dis 1982;146: 85-90.
13. Spruance SL, Crumpacker CS, Schnipper LE, Kern ER, Marlow S, Arndt KA et al. Early, patient-initiated treatment of herpes labialis with topical 10% acyclovir. Antimicrob Agents Chemother 1984;25:553-555.
14. Raborn GW, McGaw WT, Grace M. Houle L. Herpes labialis treatment with acyclovir 5 per cent ointment. Can Dent Assoc J 1989;55:135-137.
15. Fiddian AP, Ivanyi L. Topical acyclovir in the management of recurrent herpes labialis. Br J Dermatol 1983;109:321-326.
16. Whitley RJ, Levin M, Barton N, Hershey BJ, Davis G, Keeney RE et al. Infectious caused by herpes simplex virus in the immunocompromised host: natural history and topical acyclovir therapy. J Infect Dis 1984;150: 323-329.
17. Freeman DJ, Sheth NV, Spruance SL. Failure of topical acyclovir (aciclovir) in ointment to penetrate human skin. Antimicrob Agents Chemother 1986;29:730-732.
18. Raborn GW, McGaw WT, Grace M, Percy J, Samuels S. Herpes labialis treatment with acyclovir 5% modified aqueous cream: a double-blind, randomized trial. Oral Surg Oral Med Oral Pathol 1989;67:676-679.
19. Fiddian AP, Yeo JM, Stubbings R, Dean D. Successful treatment of herpes labialis with topical acyclovir. Br Med J 1983;286: 1699-1701.
20. Van Vloten WA, Swart RNJ, Pot F. Topical acyclovir therapy in patients with recurrent orofacial herpes simplex infectious. J Antimicrob Chemother 1983; 12:89-93.
21. Shaw M, King M, Best JM, Banatvala JE, Gibson JR, Klaber MR. Failure of acyclovir cream in treatment of recurrent herpes labialis. Br Med J 1985;291:7-9.
22. Spruance SL, Johnson J, Spaulding T and Aciclovir Cream Study Group. Acyclovir cream for the treatment of herpes simplex labialis: the results of two double-blind, placebo-controlled trials (abstract). Antiviral Res 2001;49:A60.
23. Raborn GW, Martel AY, Lassonde M, Lewis MA, Boon R, Spruance SL. Effective treatment of herpes simplex labialis with penciclovir cream: combined results of two trials. J Am Dent Assoc 2002;133:303-309.
24. Boon R, Goodman J, Martinez J, Marks GL, Gamble M, Welch C et al. Penciclovir cream for the treatment of sunlight-induced herpes simplex labialis: a randomized, double-blind, placebo-controlled trial. Clin Ther 2000;22:76-90.
25. Raborn GW, McGaw WT, Grace M, Tyrrell LD, Samuels SM. Oral acyclovir and herpes labialis: a randomized, double-blind, placebo-controlled study. J Am Dent Assoc 1987;115:38-42.
26. Spruance SL, Stewart JCB, Rowe NH, McKeough MB, Wenerstrom G, Freeman DJ. Treatment of recurrent herpes simplex labialis with oral acyclovir. J Infect Dis 1990;161:185-190.
27. Spruance SL, Jones TM, Blatter MM, Vargas-Cortes M, Barber J, Goldstein D et al. Oral valaciclovir for the treatment of herpes labialis: two trials of early, high-dose, short-course therapy (abstract). Antiviral Res 2002;53:A53.
28. Spruance SL, Freeman DJ, Stewart JCB, McKeough MB, Wenerstrom LG, Krueger GG et al. The natural history of ultraviolet radiation-induced herpes simplex labialis and response to therapy with peroral and topical formulations of acyclovir. J Infect Dis 1991;163:728-734.
29. Spruance SL, Rowe NH, Raborn GW, Thibodeau EA, D'Ambrosio JA, Bernstein DI. Peroral famciclovir in the treatment of experimental ultraviolet radiation-induced herpes simplex labialis: a double-blind, dose-ranging, placebo-controlled, multicenter trial. J Infect Dis 1999;179:303-310.
30. Spruance SL, McKeough MB. Combination treatment with famciclovir and a topical cortico-steroid gel versus famciclovir alone for experimental ultraviolet radiation-induced herpes simplex labialis: a pilot study. J Infect Dis 2000;181: 1906-1910.
31. Spruance SL. Prophylactic chemotherapy with acyclovir for recurrent herpes simplex labialis. J Med Virol 1993;41 (Suppl 1): 27-32.
32. Bernstein DI, Schleupner CJ, Evans TG, Blumberg DA, Bryson Y, Grafford K et al. Effect of foscarnet cream on experimental UV radiation-induced herpes labialis. Antimicrob Agents Chemother 1997;41:1961-1964.
33. Raborn GW, Martel AY, Grace MG, McGaw WT. Herpes labialis in skiers: randomized clinical trial of acyclovir cream versus placebo. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;84:641-645.
34. Raborn GW, Martel AY, Grace MG, McGaw WT. Oral acyclovir in prevention of herpes labialis. A randomized, double-blind, multi-centered clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;85: 55-59.
35. Spruance SL, Hammil ML, Hoge WS, Davis G, Mills J. Acyclovir prevents reactivation of herpes labialis in skiers. JAMA 1988; 260:1597-1599.
36. Reitano M, Tyring S, Lang W, Thoming C, Worm AM, Borelli S et al. Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study. International Valaciclovir HSV Study Group. J Infect Dis 1998;178:603-610.
37. Rooney JF, Straus SE, Mannix ML, Wohlenberg CR, Alling DW, Dumois JA et al. Oral acyclovir to suppress frequently recurrent herpes labialis. A double-blind, placebo-controlled trial. Ann Intern Med 1993;118:268-272.
38. Sacks SL, Aoki FY, Diaz-Mitoma F, Sellors J, Shafran S, Romanowski B et al. and Canadian Cooperative Study Group. Patient-initiated treatment of recurrent genital herpes with oral famciclovir: a Canadian, multicenter, placebo-controlled, dose-ranging study (abstract). Program and Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy 1994;34:11.
39. Sacks SL, Shafran SD, Diaz-Mitoma F, Trottier S, Sibbald RG, Hughes A et al. A multicenter phase I/II dose escalation study of single-dose cidofovir gel for treatment of recurrent genital herpes. Antimicrob Agents Chemother 1998;42:2996-2999.
40. Leone PA, Trottier S, Miller JM. Valacyclovir for episodic treatment of genital herpes: a shorter 3-day treatment course compared with 5-day treatment. Clin Infect Dis 2002;34:958-962.
41. Spruance SL, Stewart JCB, Freeman DJ, Brightman VJ, Cox JL, Wenerstrom G et al. Early application of topical 15% idoxuridine in dimethyl sulfoxide shortens the course of herpes simplex labialis: a multicenter placebo-controlled trial. J Infect Dis 1990;161: 191-197.
42. Anonymous. Topical Lidakol Phase III trials for oral HSV fail to show efficacy vs placebo. Antiviral Agents Bull 1996;9: 104-105.
43. Sacks SL, Thisted RA, Jones T, Barbarash RA, Mikolich D, Ruoff G et al. Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: a multicenter, randomized, placebo-controlled trial. J Am Acad Dermatol 2001;45: 222-230.
44. Evans TG, Bernstein DI, Raborn GW, Harmenberg J, Kowalski J, Spruance SL. Double-blind, randomized, placebo-controlled study of topical 5% acyclovir-1% hydrocortisone cream (ME-609) for treatment of UV radiation-induced herpes labialis. Antimicrob Agents Chemother 2002;46:1870-1874.
45. Baker DA, Deeter RG, Redder K, Phillips JA. Valaciclovir effective for suppression of recurrent HSV-1 herpes labialis (abstract). Proceedings of 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, 2000;p263.